Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Shareholders??? Equity (Tables)

v3.26.1
Shareholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2025
Shareholders’ Equity [Abstract]  
Schedule of Stock Option Activity

A summary of the stock option activity under the Company’s equity plans during the years ended December 31, 2025, 2024 and 2023 is as follows:

 

    Outstanding
share options
    Weighted-
average
exercise
price ($)
    Weighted
average
remaining
contractual
life (years)
    Aggregate
intrinsic
value
($ in thousands)
 
Options:                        
Outstanding as of December 31, 2022     6,052,214       4.166       5.570       7,761,705  
                                 
Granted     430,874       2.728                  
Forfeited     (351,671 )     7.767                  
Exercised     (1,074,162 )     0.654                  
Outstanding as of December 31, 2023     5,057,255       4.543       5.662       2,352,517  
                                 
Granted     80,000       1.91                  
Forfeited     (291,124 )     6.08                  
Exercised     (255,756 )     0.81                  
Outstanding as of December 31, 2024     4,590,375       4.62       5.87       1,364,975  
                                 
Granted     360,000                          
Forfeited     (471,914 )                        
Exercised     (394,964 )                        
 Outstanding as of December 31, 2025     4,083,497       4.38       5.53       326,730  
                                 
Exercisable as of December 31, 2025     3,577,070       4.71       5.04       326,730  
                                 
Options available for future grants     1,976,527                          
Schedule of RSUs Activity

A summary of the Company’s RSUs activity during the years ended December 31, 2025, 2024 and 2023 is as follows:

 

    Numbers of
RSUs
 
RSUs:      
Outstanding as of December 31, 2022     2,598,084  
Granted     2,908,983  
Forfeited     (370,067 )
Vested     (895,170 )
Outstanding as of December 31, 2023     4,241,830  
Granted     4,377,834  
Forfeited     (432,018 )
Vested     (3,274,523 )
Outstanding as of December 31, 2024     4,913,123  
Granted     2,755,887  
Forfeited     (389,665 )
Vested     (4,135,927 )
Outstanding as of December 31, 2025     3,143,418  
Schedule of Compensation to Employees

The following table sets forth the parameters used in computation of the options compensation to employees and service providers:

 

    Year ended December 31  
    2025     2024     2023  
                   
Expected term, in years     5.81       6.11       5.82  
Expected volatility     50.38 %     51.75 %     47%-51.75 %
Risk-free interest rate     3.7 %     4.23 %     4.15%-4.55 %
Expected dividend yield     0 %     0 %     0 %
Schedule of Stock-Based Compensation Expense to Employees

The following table presents stock-based compensation expense to employees included in the Company’s consolidated statements of operations:

 

    Year ended December 31,  
    2025     2024     2023  
                   
Research and development   $ 6,025     $ 9,684     $ 8,721  
Sales and marketing     1,594       2,384       2,229  
General and administrative     1,375       2,187       1,786  
Cost of revenues     148       287       276  
                         
Total stock-based compensation expense   $ 9,142     $ 14,542     $ 13,012